Role of mitochondria in the pathogenesis and treatment of glaucoma

Chinese Medical Journal

Volumn 126, Issue 22, 2013, Pages 4358-4365

  Yang, Xue Jiao ^a   Ge, Jian ^a   Zhuo, Ye Hong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Glaucoma; Mitochondria; Retinal ganglion cells; Trabecular meshwork cells

Indexed keywords

4 AMINOBUTYRIC ACID; BRIMONIDINE; CALCINEURIN; DORZOLAMIDE; GLUTAMATE RECEPTOR; MITOCHONDRIAL DNA; MYOCILIN; OPTINEURIN; PROTEIN BCL 2; PROTEIN BCL X; REACTIVE OXYGEN METABOLITE; TIMOLOL; TUMOR NECROSIS FACTOR ALPHA;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; EXTRACELLULAR MATRIX; GLAUCOMA; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOREACTIVITY; INTRAOCULAR PRESSURE; IRIS; LIGHT EXPOSURE; MECHANICAL STRESS; MITOCHONDRION; NONHUMAN; OPTIC NERVE; OXIDATIVE STRESS; PROTEIN EXPRESSION; RETINA GANGLION CELL; REVIEW; TRABECULAR MESHWORK;

GLAUCOMA; HUMANS; MITOCHONDRIA; RETINAL GANGLION CELLS; TRABECULAR MESHWORK;

EID: 84887576323     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131956     Document Type: Review

References (63)

1. Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol 1995; 23: 85-91.
2. Begg IS, Drance SM. Progress of the glaucomatous process related to recurrent ischaemic changes at the optic disc. Exp Eye Res 1971; 11: 141.
3. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004; 23: 53-89.
4. Alvarado JA, Yeh RF, Franse-Carman L, Marcellino G, Brownstein MJ. Interactions between endothelia of the trabecular meshwork and of Schlemm's canal: a new insight into the regulation of aqueous outflow in the eye. Trans Am Ophthalmol Soc 2005; 103: 148-163.
5. Alvarado J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology 1984; 91: 564-579.
6. Sacca SC, Pascotto A, Camicione P, Capris P, Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 2005; 123: 458-463.
7. Sihota R, Lakshmaiah NC, Walia KB, Sharma S, Pailoor J, Agarwal HC. The trabecular meshwork in acute and chronic angle closure glaucoma. Indian J Ophthalmol 2001; 49: 255-259.
8. He Y, Ge J, Tombran-Tink J. Mitochondrial defects and dysfunction in calcium regulation in glaucomatous trabecular meshwork cells. Invest Ophthalmol Vis Sci 2008; 49: 4912-4922.
9. Wentz-Hunter K, Ueda J, Shimizu N, Yue BY. Myocilin is associated with mitochondria in human trabecular meshwork cells. J Cell Physiol 2002; 190: 46-53.
10. Sakai H, Shen X, Koga T, Park BC, Noskina Y, Tibudan M, et al. Mitochondrial association of myocilin, product of a glaucoma gene, in human trabecular meshwork cells. J Cell Physiol 2007; 213: 775-784.
11. He Y, Leung KW, Zhuo YH, Ge J. Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells. Mol Vis 2009; 15: 815-825.
12. Wang J, Qu H, Tan J. A histological study on peripheral iris in primary angle closure glaucoma. Eye Sci 1993; 9: 106-109.
13. Hernandez MR, Igoe F, Neufeld AH. Cell culture of the human lamina cribrosa. Invest Ophthalmol Vis Sci 1988; 29: 78-89.
14. Kirwan RP, Leonard MO, Murphy M, Clark AF, O'Brien CJ. Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells. Glia 2005; 52: 309-324.
15. Kirwan RP, Wordinger RJ, Clark AF, O'Brien CJ. Differential global and extra-cellular matrix focused gene expression patterns between normal and glaucomatous human lamina cribrosa cells. Mol Vis 2009; 15: 76-88.
16. McElnea EM, Quill B, Docherty NG, Irnaten M, Siah WF, Clark AF, et al. Oxidative stress, mitochondrial dysfunction and calcium overload in human lamina cribrosa cells from glaucoma donors. Mol Vis 2011; 17: 1182-1191.
17. Barron MJ, Griffiths P, Turnbull DM, Bates D, Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol 2004; 88: 286-290.
18. Munemasa Y, Kitaoka Y, Kuribayashi J, Ueno S. Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model. J Neurochem 2010; 115: 1508-1519.
19. Ju WK, Kim KY, Lindsey JD, Angert M, Duong-Polk KX, Scott RT, et al. Intraocular pressure elevation induces mitochondrial fission and triggers OPA1 release in glaucomatous optic nerve. Invest Ophthalmol Vis Sci 2008; 49: 4903-4911.
20. Osborne NN, Lascaratos G, Bron AJ, Chidlow G, Wood JP. A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br J Ophthalmol 2006; 90: 237-241.
21. Osborne NN, Li GY, Ji D, Mortiboys HJ, Jackson S. Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. J Neurochem 2008;105: 2013-2028.
22. Osborne NN, Kamalden TA, Majid AS, del Olmo-Aguado S, Manso AG, Ji D. Light effects on mitochondrial photosensitizers in relation to retinal degeneration. Neurochem Res 2010; 35: 2027-2034.
23. Lascaratos G, Ji D, Wood JP, Osborne NN. Visible light affects mitochondrial function and induces neuronal death in retinal cell cultures. Vision Res 2007; 47: 1191-1201.
24. Osborne NN. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria. Prog Brain Res 2008; 173: 339-352.
25. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol 2000; 118: 666-673.
26. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000; 32: 42-50.
27. Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001; 42: 1787-1794.
28. Tezel G, Wax MB. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000; 20: 8693-8700.
29. Tezel G, Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Invest Ophthalmol Vis Sci 2004; 45: 4049-4059.
30. Bleich S, Junemann A, von Ahsen N, Lausen B, Ritter K, Beck G, et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm 2002; 109: 1499-1504.
31. Ganapathy PS, Perry RL, Tawfik A, Smith RM, Perry E, Roon P, et al. Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells. Invest Ophthalmol Vis Sci 2011; 52: 5551-5558.
32. Noske W, Hensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol 1997; 235: 551-552.
33. Tezel G, Kass MA, Kolker AE, Becker B, Wax MB. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma 1997; 6: 83-89.
34. Kallberg ME, Brooks DE, Garcia-Sanchez GA, Komaromy AM, Szabo NJ, Tian L. Endothelin 1 levels in the aqueous humor of dogs with glaucoma. J Glaucoma 2002; 11: 105-109.
35. Thanos S, Naskar R. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant. Exp Eye Res 2004; 79: 119-129.
36. Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can J Physiol Pharmacol 2008; 86: 380-393.
37. Brennan LA, Kantorow M. Mitochondrial function and redox control in the aging eye: role of MsrA and other repair systems in cataract and macular degenerations. Exp Eye Res 2009; 88: 195-203.
38. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006; 25: 490-513.
39. Ju WK, Liu Q, Kim KY, Crowston JG, Lindsey JD, Agarwal N, et al. Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells. Invest Ophthalmol Vis Sci 2007; 48: 2145-2151.
40. Mittag TW, Danias J, Pohorenec G, Yuan HM, Burakgazi E, Chalmers-Redman R, et al. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci 2000; 41: 3451-3459.
41. Ju WK, Lindsey JD, Angert M, Patel A, Weinreb RN. Glutamate receptor activation triggers OPA1 release and induces apoptotic cell death in ischemic rat retina. Mol Vis 2008; 14: 2629-2638.
42. Ju WK, Kim KY, Angert M, Duong-Polk KX, Lindsey JD, Ellisman MH, et al. Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 2009; 50: 707-716.
43. Huang W, Fileta JB, Dobberfuhl A, Filippopolous T, Guo Y, Kwon G, et al. Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc Natl Acad Sci USA 2005; 102: 12242-12247.
44. Xin X, Huber A, Meyer P, Flammer J, Neutzner A, Miller NR, et al. L-PGDS (betatrace protein) inhibits astrocyte proliferation and mitochondrial ATP production in vitro. J Mol Neurosci 2009; 39: 366-371.
45. Simpkins JW, Wang J, Wang X, Perez E, Prokai L, Dykens JA. Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets CNS Neurol Disord 2005; 4: 69-83.
46. Abu-Amero KK, Morales J, Bosley TM. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2006; 47: 2533-2541.
47. Izzotti A, Longobardi M, Cartiglia C, Sacca SC. Mitochondrial damage in the trabecular meshwork occurs only in primary open-angle glaucoma and in pseudoexfoliative glaucoma. PLoS One 2011; 6: e14567.
48. Izzotti A, Sacca SC, Longobardi M, Cartiglia C. Mitochondrial damage in the trabecular meshwork of patients with glaucoma. Arch Ophthalmol 2010; 128: 724-730.
49. Wang AG, Fann MJ, Yu HY, Yen MY. OPA1 expression in the human retina and optic nerve. Exp Eye Res 2006; 83: 1171-1178.
50. Bosley TM, Hellani A, Spaeth GL, Myers J, Katz LJ, Moster MR, et al. Down-regulation of OPA1 in patients with primary open angle glaucoma. Mol Vis 2011; 17: 1074-1079.
51. Lascaratos G, Garway-Heath DF, Willoughby CE, Chau KY, Schapira AH. Mitochondrial dysfunction in glaucoma: understanding genetic influences. Mitochondrion 2012; 12: 202-212.
52. Abu-Amero KK, Morales J, Bosley TM, Mohamed GH, Cabrera VM. The role of mitochondrial haplogroups in glaucoma: a study in an Arab population. Mol Vis 2008; 14: 518-522.
53. Sacca SC, La Maestra S, Micale RT, Larghero P, Travaini G, Baluce B, et al. Ability of dorzolamide hydrochloride and timolol maleate to target mitochondria in glaucoma therapy. Arch Ophthalmol 2011; 129: 48-55.
54. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, et al. An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta 2009; 1787: 437-461.
55. Skulachev VP. A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects. Biochemistry (Mosc) 2007; 72: 1385-1396.
56. Neroev VV, Archipova MM, Bakeeva LE, Fursova A, Grigorian EN, Grishanova AY, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Mosc) 2008; 73: 1317-1328.
57. Tatton WG, Chalmers-Redman RM, Sud A, Podos SM, Mittag TW. Maintaining mitochondrial membrane impermeability. an opportunity for new therapy in glaucoma? Surv Ophthalmol 2001; 45 Suppl 3: S277-S283; discussion S295-S296.
58. Dai Y, Weinreb RN, Kim KY, Nguyen D, Park S, Sun X, et al. Inducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive rats. Invest Ophthalmol Vis Sci 2011; 52: 2468-2476.
59. Ju WK, Kim KY, Duong-Polk KX, Lindsey JD, Ellisman MH, Weinreb RN. Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma. Mol Vis 2010; 16: 1331-1342.
60. Zhao K, Luo G, Zhao GM, Schiller PW, Szeto HH. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J Pharmacol Exp Ther 2003; 304: 425-432.
61. Chen M, Liu B, Gao Q, Zhuo Y, Ge J. Mitochondria-targeted peptide MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2011; 52: 7027-7037.
62. Chen K, Zhang Q, Wang J, Liu F, Mi M, Xu H, et al. Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Res 2009; 1279: 131-138.
63. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci 2007; 48: 681-691.